Skip to Content

Tyzeka Novartis - Treatment for Chronic Hepatitis B

Tyzeka is a synthetic thymidine nucleoside analogue indicated for the treatment of chronic hepatitis B in adult patients with evidence of viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.

Posted: October 2006

Related Articles:

Tyzeka (telbivudine) FDA Approval History